Cite
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
MLA
Nadia Marascio, et al. “Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4.” Cells, vol. 8, no. 5, May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ead6f6ddd43224e086b1ffdcc353cada&authtype=sso&custid=ns315887.
APA
Nadia Marascio, Giuseppe Greco, Carlo Torti, Francesca Serapide, Francesco Casalinuovo, Aida Giancotti, Vincenzo Pisani, Maria Carla Liberto, Chiara Costa, Giovanni Matera, Grazia Pavia, Enrico Maria Trecarichi, Giorgio Settimo Barreca, & Maria Mazzitelli. (2019). Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4. Cells, 8(5).
Chicago
Nadia Marascio, Giuseppe Greco, Carlo Torti, Francesca Serapide, Francesco Casalinuovo, Aida Giancotti, Vincenzo Pisani, et al. 2019. “Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4.” Cells 8 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ead6f6ddd43224e086b1ffdcc353cada&authtype=sso&custid=ns315887.